Atlas FDA

C-KIT PHARMDX

FDA premarket approval P040011/S002 · decided 2012-11-02

Approval details

PMA number
P040011
Supplement
S002
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
C-KIT PHARMDX
Generic name
Immunohistochemistry antibody assay, c-kit
Applicant
Dako North America, Inc.
Date received
2012-10-16
Decision date
2012-11-02
Days to decision
17 days
Decision code
APPR
Product code
NKF
Advisory committee
Pathology
Expedited review
No
Location
Carpinteria, CA
Statement
APPROVAL FOR CHANGING THE COMPANY PREFIX TO THE DEVICE NAME (FROM DAKOCYTOMATION C-KIT PHARMDX TO C-KIT PHARMDX). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME C-KIT PHARMDX.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
FLEX Monoclonal Rabbitt Anti-Human Estrogen Receptor a, Clone EP1, Ready-to-Use (Link); FLEX Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 636, Ready-to-Use (Link) (K160922)Dako North America, Inc.2016-05-03
MONOCLONAL MOUSE ANTI-HUMAN PROGESTERONE RECEPTOR, CLONE PGR 636, READY-TO-USE (LINK) (K130861)Dako North America, Inc.2013-12-09
MONOCLONAL RABBIT ANTI-HUMAN ESTROGEN RECEPTOR (ER) A, CLONE EPI (K120663)Dako North America, Inc.2013-02-12
MONOCLONAL RABBIT ANTI HUMAN ESTROGEN RECEPTOR ALPHA ANTIBODY CLONE SP1, MODEL M3634 (K081286)Dako North America, Inc.2009-05-08